Publications

2021

1: Kerkmeijer LGW, Pos FJ, Haustermans K, van der Heide UA. (2021) Reply to I. R. Vogelius et al. J Clin Oncol. Online ahead of print.
2: Dechambre, David ; Vander Veken, Loïc ; Delor, Antoine ; Sterpin, Edmond ; Vanneste, Françoise ; Geets, Xavier. Feasibility of a TPS-integrated method to incorporate tumor motion in the margin recipe.. In: Medical dosimetry, (2021). doi:10.1016/j.meddos.2021.02.002 (Accepté/Sous presse). http://hdl.handle.net/2078.1/245472
3: Glatzer, Markus ; Faivre-Finn, Corinne ; De Ruysscher, Dirk ; Widder, Joachim ; Van Houtte, Paul ; Troost, Esther G C ; Slotman, Ben J ; Ramella, Sara ; Pöttgen, Christoph ; Peeters, Stephanie T H ; Nestle, Ursula ; McDonald, Fiona ; Le Pechoux, Cecile ; Dziadziuszko, Rafal ; Belderbos, José ; Ricardi, Umberto ; Manapov, Farkhad ; Lievens, Yolande ; Geets, Xavier ; Dieckmann, Karin ; Guckenberger, Matthias ; Andratschke, Nicolaus ; Süveg, Krisztian ;Putora, Paul M. Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria inclinical routine.. In: Radiotherapy and oncology, Vol. 154, p. 269-273 (2021). doi:10.1016/j.radonc.2020.10.043. http:/ /hdl.handle.net/2078.1/245474
4: Piraux, Elise ; Caty, Gilles ; Renard, Laurette ; Vancraeynest, David ; Tombal, Bertrand ; Geets, Xavier ; Reychler,Gregory. Effects of high-intensity interval training compared with resistance training in prostate cancer patientsundergoing radiotherapy: a randomized controlled trial.. In: Prostate Cancer and Prostatic Diseases, Vol. 24, no. 1,p. 156-165 (2021). doi:10.1038/s41391-020-0259-6. http://hdl.handle.net/2078.1/232125
5: Aznar, M.C., Bacchus, C., Coppes, R.P., Deutsch, E., Georg, D., Haustermans, K., Hoskin, P., Krause, M., Lartigau, E.F., Löck, S., Offersen, B., Overgaard, J., Thwaites, D.I., van der Kogel, A.J., van der Heide, U.A., Valentini, V., Baumann, M. (2021). Radiation oncology in the new virtual and digital era. RADIOTHERAPY AND ONCOLOGY, 154, A1-A4.
6: Thomas, M., De Roover, R., van der Merwe, S., Lambrecht, M., Defraene, G., Haustermans, K. (2021). The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 26, 8-14.
7: Schmoll, H-J., Stein, A., Van Cutsem, E., Price, T., Hofheinz, R.D., Nordlinger, B., Daisne, J-F., Janssens, J., Brenner, B., Reinel, H., Hollerbach, S., Caca, K., Fauth, F., Hannig, C.V., Zalcberg, J., Tebbutt, N., Mauer, M.E., Marreaud, S., Lutz, M.P., Haustermans, K. (2021). Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. JOURNAL OF CLINICAL ONCOLOGY, 39 (1), 17-29.
8: Kerkmeijer, L.G W., Groen, V.H., Pos, F.J., Haustermans, K., Monninkhof, E.M., Smeenk, R.J., Kunze-Busch, M., de Boer, J.C J., van der Voort van Zijp, J., van Vulpen, M., Draulans, C., van den Bergh, L., Isebaert, S., van der Heide, U.A. (2021). Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial. JOURNAL OF CLINICAL ONCOLOGY. 39(7): 787-796.
9: Barragán-Montero AM, Thomas M, Defraene G, Michiels S, Haustermans K, Lee JA, Sterpin E. (2021). Deep learning dose prediction for IMRT of esophageal cancer: The effect of data quality and quantity on model performance. PHYS MED, 83:52-63.
10: Franco NR, Massi MC, Ieva F, Manzoni A, Paganoni AM, Zunino P, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Veldwijk MR, Herskind C, Avuzzi B, Noris Chiorda B, Valdagni R, Azria D, Farcy-Jacquet MP, Brengues M, Rosenstein BS, Stock RG, Vega A, Aguado-Barrera ME, Sosa-Fajardo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T; REQUITE Consortium Collaborators. (2021). Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. RADIOTHER ONCOL 159:241-248.
11: Orazem M, Draulans C, Spaas M, Van Cutsem E, Debecker M, De Meerleer G, Tejpar S, Dekervel J, Haustermans K. (2021). A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy. CLIN J GASTROENTEROL. Online ahead of print.
12: Ahmadi Bidakhvidi N, Laenen A, Jentjens S, Deroose CM, Van Laere K, De Wever L, Mai C, Berghen C, De Meerleer G, Haustermans K, Joniau S, Everaerts W, Goffin K. (2021). Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer. EJNMMI Res. 11(1):41.
13: Draulans C, Pos F, Smeenk RJ, Kerkmeijer L, Vogel WV, Nagarajah J, Janssen M, Mai C, Heijmink S, van der Leest M, Zámecnik P, Oyen R, Isebaert S, Maes F, Joniau S, Kunze-Busch M, De Roover R, Defraene G, van der Heide UA, Goffin K, Haustermans K. (2021) 68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability. PRACT RADIAT ONCOL, 11(3):202-211.
14: Kerkmeijer LGW, Pos FJ, Haustermans K, van der Heide UA. (2021) Reply to I. R. Vogelius et al. J Clin Oncol. Online ahead of print.

2020

1: Kazemifar, Samaneh ; Barragan Montero, Ana Maria ; Souris, Kevin ; Rivas, Sara T. ; Timmerman, Robert ; Park, Yang K. ; Jiang, Steve ; Geets, Xavier ; Sterpin, Edmond ; Owrangi, Amir. Dosimetric evaluation of synthetic CT generated with GANs for MRI-only proton therapy treatment planning of brain tumors. In: Journal of Applied Clinical Medical Physics, Vol. 21, no. 5, p. 76-86 (2020). doi:10.1002/acm2.12856. http://hdl.handle.net/2078.1/235307
2: Le Pechoux, Cecile ; Faivre-Finn, Corinne ; Ramella, Sara ; McDonald, Fiona ; Manapov, Farkhad ; Putora, Paul Martin ; Slotman, Ben ; De Ruysscher, Dirk ; Ricardi, Umberto ; Geets, Xavier ; Belderbos, José ; Pöttgen, Christoph ; Dziadiuszko, Rafal ; Peeters, Stephanie ; Lievens, Yolande ; Hurkmans, Coen ; Van Houtte, Paul ; Nestle, Ursula. ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.. In: Radiotherapy and oncology, Vol. 152, p. 89-95 (2020). doi:10.1016/j.radonc.2020.07.012. http://hdl.handle.net/2078.1/245482
3: Vander Veken, Loïc ; Dechambre, David ; Michiels,Seven ; Cohilis, Marie ; Souris, Kevin ; Lee, John Aldo ; Geets, Xavier. Improvement of kilovoltage intrafraction monitoring accuracy through gantry angles selection. In: Biomedical Physics & Engineering Express, Vol. 6, no.6, p. 1-12 (2020). doi:10.1088/2057-1976/abb18e. http://hdl.handle.net/2078.1/244537
4: Sanduleanu, Sebastian ; Jochems, Arthur ; Upadhaya, Taman ; Even, Aniek J G ; Leijenaar, Ralph T H ; Dankers, Frank J W M ; Klaassen, Remy ; Woodruff, Henry C ; Hatt, Mathieu ; Kaanders, Hans J A M ; Hamming-Vrieze, Olga ; van Laarhoven, Hanneke W M ; Subramiam, Rathan M ; Huang, Shao Hui ; O'Sullivan, Brian ; Bratman, Scott V ; Dubois, Ludwig J ; Miclea, Razvan L ; Di Perri, Dario ; Geets, Xavier ; Crispin-Ortuzar, Mireia ; Apte, Aditya ; Deasy, Joseph O ; Oh, Jung Hun ; Lee, Nancy Y ; Humm, John L ; Schöder, Heiko ; De Ruysscher, Dirk ; Hoebers, Frank ; Lambin, Philippe. Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures.. In: Radiotherapy and oncology, Vol. 153, p. 97-105 (2020). doi:10.1016/j.radonc.2020.10.016. http://hdl.handle.net/2078.1/245480
5: Borderias Villarroel, Elena Lucia ; Geets, Xavier ; Sterpin, Edmond. Online adaptive dose restoration in intensity modulated proton therapy of lung cancer to account for inter-fractional density changes. In: Physics and Imaging in Radiation Oncology, Vol. 15, no.xx, p. 30-37 (2020). doi:10.1016/j.phro.2020.06.004. http://hdl.handle.net/2078.1/235305
6: Lieverse, Relinde I Y ; Van Limbergen, Evert J ; Oberije, Cary J G ; Troost, Esther G C ; Hadrup, Sine R ; Dingemans, Anne-Marie C ; Hendriks, Lizza E L ; Eckert, Franziska ; Hiley, Crispin ; Dooms, Christophe ; Lievens, Yolande ; de Jong, Monique C ; Bussink, Johan ; Geets, Xavier ; Valentini, Vincenzo ; Elia, Giuliano ; Neri, Dario ; Billiet,Charlotte ; Abdollahi, Amir ; Pasquier, David ; Boisselier, Pierre ; Yaromina, Ala ; De Ruysscher, Dirk ; Dubois,Ludwig J ; Lambin, Philippe. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.. In: BMC cancer, Vol. 20, no.1, p. 557 [1-10] (2020). doi:10.1186/s12885-020-07055-1. http://hdl.handle.net/2078.1/245488
7: Pariset, E, Penninckx, S, Degorre, C, Guiet, E, Lopez Macha, A, Cekanaviciute, E, Snijders, A, Mao, J-H, Paris, F & Costes, S 2020, '53BP1 Repair Kinetics for Prediction of In Vivo Radiation Susceptibility in 15 Mouse Strains', Radiation Research, vol. 194, no. 5, pp. 485-499. https://doi.org/10.1667/RADE-20-00122.1
8: Schuemann, J, Bagley, A, Berbeco, R, Bromma, K, Butterworth, KT, Byrne, H, Chithrani, DB, Cho, SH, Cook, JR, Favaudon, V, Gholami, YH, Gargioni, E, Hainfeld, JF, Hespeels, F, Heuskin, A-C, Ibeh, UM, Kuncic, Z, Kunjachan, S, Lacombe, S, Lucas, S, Lux, F, McMahon, SJ, Nevozhay, D, Ngwa, W, Payne, JD, Penninckx, S, Porcel, E, Prise, KM, Rabus, H, Ridwan, SM, Rudek, B, Sanche, L, Singh, B, Smilowitz, HM, Sokolov, KV, Sridhar, S, Stanishevskiy, Y, Sung, W, Tillement, O, Virani, NA, Yantasee, W & Krishnan, S 2020, 'Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions', Physics in Medicine and Biology. https://doi.org/10.1088/1361-6560/ab9159
9: Konings, K., Vandevoorde, C., Baselet, B., Baatout, S., & Moreels, M. (2020). Combination Therapy With Charged Particles and Molecular Targeting - A Promising Avenue to Overcome Radioresistance. Frontiers in Oncology, 10, 1-21. [128]. https://doi.org/10.3389/fonc.2020.00128
10: Henthorn, NT, Sokol, O, Durante, M, De Marzi, L, Pouzoulet, F, Miszczyk, J, Olko, P, Brandenburg, S, van Goethem, MJ, Barazzuol, L, Tambas, M, Langendijk, JA, Davídková, M, Vondráĉek, V, Bodenstein, E, Pawelke, J, Lomax, AJ, Weber, DC, Dasu, A, Stenerlöw, B, Poulsen, PR, Sørensen, BS, Grau, C, Sitarz, MK, Heuskin, AC, Lucas, S, Warmenhoven, JW, Merchant, MJ, Mackay, RI & Kirkby, KJ 2020, 'Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project', Frontiers in Physics, vol. 8, 565055. https://doi.org/10.3389/fphy.2020.565055
11: Penninckx, S, Heuskin, AC, Michiels, C & Lucas, S 2020, 'Gold nanoparticles as a potent radiosensitizer: A transdisciplinary approach from physics to patient', Cancers, vol. 12, no. 8, 2021, pp. 1-361. https://doi.org/10.3390/cancers12082021
12: Longton, E, Lawson, G, Bihin, B, Mathieu, I, Hanin, FX, Deheneffe, S, Vander Borght, T, Laloux, M & Daisne, JF 2020, 'Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study', International Journal of Radiation Oncology Biology Physics, vol. 107, no. 4, pp. 652-661. https://doi.org/10.1016/j.ijrobp.2020.03.021
13: HUART, CAMILLE, Chen, J-W, Le Calve, B, MICHIELS, C & WERA, A-C 2020, 'Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?', International Journal of Molecular Sciences, vol. 21, no. 13, 4767, pp. 1-29. https://doi.org/10.3390/ijms21134767
14: Haye, E, Job, N, Wang, Y, Penninckx, S, Stergiopoulos, V, Tumanov, N, Cardinal, M, Busby, Y, Colomer, JF, Su, BL, Pireaux, JJ & Houssiau, L 2020, 'ZnO/Carbon xerogel photocatalysts by low-pressure plasma treatment, the role of the carbon substrate and its plasma functionalization', Journal of Colloid and Interface Science, vol. 570, pp. 312-321. https://doi.org/10.1016/j.jcis.2020.03.015
15: Marx, S, Dal Maso, T, Chen, JW, Bury, M, Wouters, J, Michiels, C & Le Calvé, B 2020, 'Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process', Seminars in cancer biology, vol. 60, pp. 96-106. https://doi.org/10.1016/j.semcancer.2019.08.018
16: Penninckx, S, Pariset, E, Uriarte Acuna, A, Lucas, S & Costes, S 2020, 'Considering Cell Proliferation to Optimize Detection of Radiation-Induced 53BP1-Positive Foci in 15 Mouse Strains Ex Vivo', Radiation Research.
17: Hespeels, B, Penninckx, S, Cornet, V, Bruneau, L, Bopp, C, Baumlé, V, Redivo, B, Heuskin, AC, Moeller, R, Fujimori, A, Lucas, S & Van Doninck, K 2020, 'Iron Ladies: How Desiccated Asexual Rotifer Adineta vaga Deal With X-Rays and Heavy Ions?', Frontiers in Microbiology, vol. 11, 1792, pp. 1792. https://doi.org/10.3389/fmicb.2020.01792
18: Klawer EME, van Houdt PJ, Simonis FFJ, van den Berg CAT, Pos FJ, Heijmink SWTPJ, Isebaert S, Haustermans K, van der Heide UA. (2020). Erratum to: Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (Magn Reson Med. 2019; 81: 3358-3369). MAGN RESON MED Nov 3. Online ahead of print.
19: Thomas, M., Mortensen, H.R., Hoffmann, L., Møller, D.S., Troost, E.G C., Muijs, C.T., Berbee, M., Bütof, R., Nicholas, O., Radhakrishna, G., Defraene, G., Nafteux, P., Nordsmark, M., Haustermans, K. (2020). Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer. RADIOTHERAPY AND ONCOLOGY, 156, 102-112.
20: De Roover, R., Hansen, R., Crijns, W., Muurholm, C.G., Poels, K., Skouboe, S., Haustermans, K., Poulsen, P.R., Depuydt, T. (2020). Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements. RADIOTHERAPY AND ONCOLOGY, 156, 10-18.
21: Draulans, C., Berghen, C., De Meerleer, G., Joniau, S., Isebaert, S., Haustermans, K. with Haustermans, K. (corresp. author) (2020). Radiotherapie bij primaire prostaatkanker: als minder meer wordt. TIJDSCHRIFT VOOR GENEESKUNDE, 76 (21), 1098-1106.
22: Massi, M.C., Gasperoni, F., Ieva, F., Paganoni, A.M., Zunino, P., Manzoni, A., Franco, N.R., Veldeman, L., Ost, P., Fonteyne, V., Talbot, C.J., Rattay, T., Webb, A., Symonds, P.R., Johnson, K., Lambrecht, M., Haustermans, K., De Meerleer, G., de Ruysscher, D., Vanneste, B., Van Limbergen, E., Choudhury, A., Elliott, R.M., Sperk, E., Herskind, C., Veldwijk, M.R., Avuzzi, B., Giandini, T., Valdagni, R., Cicchetti, A., Azria, D., Jacquet, M-P.F., Rosenstein, B.S., Stock, R.G., Collado, K., Vega, A., Aguado-Barrera, M.E., Calvo, P., Dunning, A.M., Fachal, L., Kerns, S.L., Payne, D., Chang-Claude, J., Seibold, P., West, C.M L., Rancati, T. (2020). A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. FRONTIERS IN ONCOLOGY, 10, Art.No. ARTN 541281.
23: Draulans, C., De Roover, R., van der Heide, U.A., Kerkmeijer, L., Smeenk, R.J., Pos, F., Vogel, W.V., Nagarajah, J., Janssen, M., Isebaert, S., Maes, F., Mai, C., Oyen, R., Joniau, S., Kunze-Busch, M., Goffin, K., Haustermans, K. (2020). Optimal(68)Ga-PSMA and(18)F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING.
24: Thomas, M., Defraene, G., Levis, M., Sterpin, E., Lambrecht, M., Ricardi, U., Haustermans, K. (2020). A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 16, 50-53.
25: Beyls, C., Haustermans, K., Deroose, C.M., Pans, S., Vanbeckevoort, D., Verslype, C., Dekervel, J. (2020). Could Autoimmune Disease Contribute to the Abscopal Effect in Metastatic Hepatocellular Carcinoma? HEPATOLOGY, 72 (3), 1152-1154.
26: Berghen, C., Joniau, S., Laenen, A., Devos, G., Rans, K., Goffin, K., Haustermans, K., De Meerleer, G. (2020). Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial. FUTURE ONCOLOGY, 16 (27), 2035-2044.
27: Brunner, T., Haustermans, K., Huguet, F., Morganti, A., Mukherjee, S., Belka, C., Krempien, R., Hawkins, M., Valentini, V., Roeder, F. (2020). ESTRO ACROP guidelines for target volume definition in pancreatic cancer. RADIOTHERAPY AND ONCOLOGY, 154, 60-69.
28: Draulans, C., Van Damme, N., Isebaert, S., Everaerts, W., Silversmit, G., Joniau, S., De Meerleer, G., Van Eycken, E., Haustermans, K., Ameye, F., Roumeguère, T., Dekuyper, P., Quackels, T., Van Cleynenbreugel, B. (2020). Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a populationbased cohort study. ACTA ONCOLOGICA, 59 (8), 904-910.
29: van Schie, M.A., Janssen, T.M., Eekhout, D., Walraven, I., Pos, F.J., de Ruiter, P., Kotte, A.N T J., Monninkhof, E.M., Kerkmeijer, L.G W., Draulans, C., de Roover, R., Haustermans, K., Kunze-Busch, M., Smeenk, R.J., van der Heide, U.A. (2020). Knowledge-based assessment of focal dose escalation treatment plans in prostate cancer. INTERNATIONAL JOURNAL OF RADIOTHERAPY ONCOLOGY, BIOLOGY & PHYSICS, 108 (4), 1055-1062.
30: Pauwels, E., Van Binnebeek, S., Vandecaveye, V., Baete, K., Vanbilloen, H., Koole, M., Mottaghy, F.M., Haustermans, K., Clement, P.M., Nackaerts, K., Van Cutsem, E., Verslype, C., Deroose, C.M. (2020). Inflammation-Based Index and 68Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC. JOURNAL OF NUCLEAR MEDICINE, 61 (7), 1014-1020.
31: Gregoire, V., Guckenberger, M., Haustermans, K., Lagendijk, J.J W., Menard, C., Poetter, R., Slotman, B.J., Tanderup, K., Thorwarth, D., van Herk, M., Zips, D. (2020). Image guidance in radiation therapy for better cure of cancer. MOLECULAR ONCOLOGY, 14 (7), 1470-1491.
32: Oldenburger, E., Haustermans, K. (2020). Response to Schuler et al. patient-reported outcome measures (PROMs) in palliative radiotherapy. RADIOTHERAPY & ONCOLOGY.
33: Draulans, C., van der Heide, U.A., Haustermans, K., Pos, F.J., van der Voort van Zyp, J., De Boer, H., Groen, V.H., Monninkhof, E.M., Smeenk, R.J., Kunze-Busch, M., De Roover, R., Depuydt, T., Isebaert, S., Kerkmeijer, L.G W. (2020). Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer. RADIOTHERAPY & ONCOLOGY, 147, 92-98.
34: Berghen, C., Joniau, S., Rans, K., Devos, G., Poels, K., Slabbaert, K., Dumez, H., Albersen, M., Goffin, K., Haustermans, K., De Meerleer, G. (2020). Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial. BMC CANCER, 20 (1).
35: Berghen, C., Joniau, S., Vulsteke, C., Albersen, M., Devos, G., Rans, K., Haustermans, K., De Meerleer, G. (2020). Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news. E-CANCER MEDICAL SCIENCE, 14, Art.No. ARTN 1036.
36: Fokas, E., Glynne-Jones, R., Appelt, A., Beets-Tan, R., Beets, G., Haustermans, K., Marijnen, C., Minsky, B.D., Ludmir, E., Quirke, P., Sebag-Montefiore, D., Garcia-Aguilar, J., Gambacorta, M.A., Valentini, V., Buyse, M., Rodel, C. (2020). Outcome measures in multimodal rectal cancer trials. LANCET ONCOLOGY, 21 (5), E252-E264.
37: Oldenburger, E., Oldenburger, F., Coolbrandt, A., Isebaert, S., Neyens, I., Sevenants, A., Van Audenhove, C., Haustermans, K. (2020). The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review. RADIOTHERAPY & ONCOLOGY, 149, 94-103.
38: Beyls, C., Haustermans, K., Deroose, C.M., Pans, S., Vanbeckevoort, D., Verslype, C., Dekervel, J. (2020). Could autoimmune disease contribute to the abscopal effect in metastatic hepatocellular carcinoma? HEPATOLOGY.
39: Tchelebi, L.T., Haustermans, K., Scorsetti, M., Hosni, A., Huguet, F., Hawkins, M.A., Dawson, L.A., Goodman, K.A. (2020). Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19. RADIOTHERAPY & ONCOLOGY, 148, 194-200.
40: Marijnen, C.A M., Peters, F.P., Rödel, C., Bujko, K., Haustermans, K., Fokas, E., Glynne-Jones, R., Valentini, V., Spindler, K-L.G., Guren, M.G., Maingon, P., Calvo, F.A., Pares, O., Glimelius, B., Sebag-Montefiore, D. (2020). International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. RADIOTHERAPY & ONCOLOGY, 148, 213-215.
41: Draulans, C., Everaerts, W., Isebaert, S., Van Bruwaene, S., Gevaert, T., Oyen, R., Joniau, S., Lerut, E., De Wever, L., Laenen, A., Weynand, B., Defraene, G., Vanhoutte, E., De Meerleer, G., Haustermans, K. (2020). Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection. JOURNAL OF UROLOGY, 203 (4), 713-718.
42: Chys, B., Devos, G., Everaerts, W., Albersen, M., Moris, L., Claessens, F., De Meerleer, G., Haustermans, K., Briganti, A., Chlosta, P., Gontero, P., Graefen, M., Gratzke, C., Karnes, R.J., Kneitz, B., Marchioro, G., Salas, R.S., Spahn, M., Tombal, B., Van Der Poel, H., Walz, J., Van Poppel, H., Joniau, S. (2020). Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis. FRONTIERS IN ONCOLOGY, 10, Art.No. ARTN 246.
43: Bulens, P., Couwenberg, A., Intven, M., Debucquoy, A., Vandecaveye, V., Van Cutsem, E., D'Hoore, A., Wolthuis, A., Mukherjee, P., Gevaert, O., Haustermans, K. (2020). Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics. RADIOTHERAPY & ONCOLOGY, 142, 246-252.
44: Valentini, V., Marijnen, C., Beets, G., Bujko, K., De Bari, B., Cervantes, A., Chiloiro, G., Coco, C., Gambacorta, M.A., Glynne-Jones, R., Haustermans, K., Meldolesi, E., Peters, F., Rödel, C., Rutten, H., van de Velde, C., Aristei, C. (2020). The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. RADIOTHERAPY & ONCOLOGY, 142, 6-16.
45: Wagner, A.D., Lordick, F., Grabsch, H., Terashima, M., Terada, M., Yoshikawa, T., Boku, N., Kataoka, K., Smyth, E.C., Mauer, M., Haustermans, K., Moehler, M.H. (2020). Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. EUROPEAN JOURNAL OF CANCER, 124, 67-76.

2019

1: Penninckx, S, Cekanaviciute, E, Degorre, C, Guiet, E, Viger, L, Lucas, S & Costes, SV 2019, 'Dose, LET and Strain Dependence of Radiation-Induced 53BP1 Foci in 15Mouse Strains Ex Vivo Introducing Novel DNA Damage Metrics', Radiation Research, vol. 192, no. 1, pp. 1-12. https://doi.org/10.1667/RR15338.1
2: Christodoulou, Marianna ; Blackhall, Fiona ; Mistry, Hitesh ; Leylek, Ahmet ; Knegjens, Joost ; Remouchamps, Vincent ; Martel-Lafay, Isabelle ; Farré, Núria ; Zwitter, Matjaž ; Lerouge, Delphine ; Pourel, Nicolas ; Janicot, Henri ; Scherpereel, Arnaud ; Tissing-Tan, Caroline ; Peignaux, Karin ; Geets, Xavier ; Konopa, Krzysztof ; Faivre-Finn, Corinne. Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.. In: Journal of thoracic oncology, Vol. 14, no. 1, p. 63-71 (2019). doi:10.1016/j.jtho.2018.09.027. http://hdl.handle.net/2078.1/207924
3: Toscano, S. ; Souris, Kevin ; Gomà, C. ; Barragan Montero, Ana Maria ; Puydupin, S. ; Stappen, F.V. ; Janssens, G. ; Matic, A. ; Geets, Xavier ; Sterpin, Edmond. Impact of machine log-files uncertainties on the quality assurance of proton pencil beam scanning treatment delivery. In: Physics in medicine and biology, Vol. 64, no.9, p. 095021 (2019). doi:10.1088/1361-6560/ab120c. http://hdl.handle.net/2078.1/216285
4: Schubert, Thomas ; Geets, Xavier. Innovations 2018 en chirurgie orthopédique et traumatologie : La radiothérapie préopératoire des sarcomes des tissus mous. In: Louvain médical, Vol. 138, no.2, p. 90-91 (2019). http://hdl.handle.net/2078.1/217806
5: Audag, Nicolas ; Van Ooteghem, Geneviève ; Liistro, Giuseppe ; Salini, Armand ; Geets, Xavier ; Reychler, Gregory. Intrapulmonary percussive ventilation leading to 20-minutes breath-hold potentially useful for radiation treatments. In: Radiotherapy and Oncology, Vol. 141, p. 292-295 (2019). doi:10.1016/j.radonc.2019.09.024. http://hdl.handle.net/2078.1/227893
6: Van Ooteghem, Geneviève ; Dasnoy-Sumell, Damien ; Lee, John Aldo ; Geets, Xavier. Mechanically-assisted and non-invasive ventilation for radiation therapy: A safe technique to regularize and modulate internal tumour motion. In: Radiotherapy and Oncology, Vol. 141, p. 283-291 (2019). doi:10.1016/j.radonc.2019.09.021. http://hdl.handle.net/2078.1/226698
7: Van Ooteghem, Geneviève ; Dasnoy-Sumell, Damien ; Lambrecht, Maarten ; Reychler, Gregory ; Liistro, Giuseppe ; Sterpin, Edmond ; Geets, Xavier. Mechanically-assisted non-invasive ventilation: A step forward to modulate and to improve the reproducibility of breathing-related motion in radiation therapy. In: Radiotherapy and Oncology, Vol. 133, p. 132-139 (2019). doi:10.1016/j.radonc.2018.12.026. http://hdl.handle.net/2078.1/212856
8: Barragan Montero, Ana Maria ; Nguyen, Dan ; Lu, Weiguo ; Lin, Mu-Han ; Norouzi-Kandalan, Roya ; Geets, Xavier ; Sterpin, Edmond ; Jiang, Steve. Three-dimensional dose prediction for lung IMRT patients with deep neural networks: robust learning from heterogeneous beam configurations. In: Medical physics, , p. [1-13] (2019). doi:10.1002/ mp.13597 (Accepté/Sous presse). http://hdl.handle.net/2078.1/218631
9: Penninckx, S, Heuskin, A-C, Michiels, C & Lucas, S 2019, 'Thioredoxin Reductase Activity Predicts Gold Nanoparticle Radiosensitization Effect', Nanomaterials, vol. 9, no. 2, 295, pp. 295. https://doi.org/10.3390/nano9020295
10: Schmit, K, Chen, J-W, Ayama-Canden, S, Fransolet, M, Finet, L, Demazy, C, D’Hondt, L, Graux, C & Michiels, C 2019, 'Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin', Cell Death and Disease, vol. 10, no. 12, 919, pp. 919. https://doi.org/10.1038/s41419-019-2088-x
11: Wéra, AC, Lobbens, A, Stoyanov, M, Lucas, S & Michiels, C 2019, 'Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation', Cell Cycle, vol. 18, no. 15, pp. 1770-1783. https://doi.org/10.1080/15384101.2019.1632640
12: Longton, E, Lawson, G, Deheneffe, S, Bihin, B, Mathieu, I, Hanin, F, Borght, TV & Daisne, J 2019, 'OC-0389 Individualized prophylactic irradiation based on sentinel lymph node(s) identification in cN0 HNSCC', Radiotherapy and Oncology, vol. 133, no. Supplément 1, pp. S195-S196. https://doi.org/10.1016/s0167-8140(19)30809-6
13: Hespeels, F, Lucas, S, Tabarrant, T, Scifoni, E, Kraemer, M, Chêne, G, Strivay, D, Tran, HN & Heuskin, A-C 2019, 'Experimental measurements validate the use of the binary encounter approximation model to accurately compute proton induced dose and radiolysis enhancement from gold nanoparticles', Physics in Medicine and Biology, vol. 64, no. 6, 065014. https://doi.org/10.1088/1361-6560/ab0516
14: Li, S, Bouchy, S, Penninckx, S, Marega, R, Fichera, O, Gallez, B, Feron, O, Martinive, P, Heuskin, A-C, Michiels, C & Lucas, S 2019, 'Antibody-functionalized gold nanoparticles as tumor targeting radiosensitizers for proton therapy', Nanomedicine, vol. 14, no. 3, pp. 317-333. https://doi.org/10.2217/nnm-2018-0161
15: Daems, N, Penninckx, S, Nelissen, I, Van Hoecke, K, Cardinaels, T, Baatout, S, Michiels, C, Lucas, S & Aerts, A 2019, 'Gold nanoparticles affect the antioxidant status in selected normal human cells', Nanomedicine, vol. 14, pp. 4991-5015. https://doi.org/10.2147/IJN.S203546
16: Konings, K., Belmans, N., Vermeesen, R., Baselet, B., Lamers, G., Janssen, A., ... Moreels, M. (2019). Targeting the Hedgehog pathway in combination with X-ray or carbon ion radiation decreases migration of MCF-7 breast cancer cells. International Journal of Oncology, 55(6), 1339-1348. https://doi.org/10.3892/ijo.2019.4901
17: The combination of particle irradiation with the hedgehog inhibitor GANT61 differently modulates the radiosensitivity and migration of cancer cells compared to X-Ray irradiation. / Konings, Katrien; Belmans, Niels; Vermeesen, Randy; Janssen, Ann; Baatout, Sarah; Moreels, Marjan; Baselet, Bjorn. In: Frontiers in Oncology, Vol. 9, 14.05.2019, p. 1-16.
18: Pauwels, E., Van Binnebeek, S., Vandecaveye, V., Baete, K., Vanbilloen, H., Koole, M., Mottaghy, F.M., Haustermans, K., Clement, P.M., Nackaerts, K., Van Cutsem, E., Verslype, C., Deroose, C.M. (2019). Inflammation-based index and 68Ga-DOTATOC PET-derived uptake and volumetric parameters predict outcome in neuroendocrine tumor patients treated with 90Y-DOTATOC. J Nucl Med.
19: Thomas, M., Defraene, G., Lambrecht, M., Deng, W., Moons, J., Nafteux, P., Lin, S.H., Haustermans, K. (2019). NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer. RADIOTHERAPY AND ONCOLOGY, 141, 33-40.
20: Konings, K., Belmans, N., Vermeesen, R., Baselet, B., Lamers, G., Janssen, A., Isebaert, S., Baatout, S., Haustermans, K., Moreels, M. (2019). Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cells. INTERNATIONAL JOURNAL OF CANCER, 55(6), 1339-1348.
21: Wagner, A.D., Lordick, F., Grabsch, H.I., Terashima, M., Terada, M., Yoshikawa, T., Boku, N., Kataoka, K., Smyth, E.C., Mauer, M., Haustermans, K., Moehler, M.H. (2019). Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. EUROPEAN JOURNAL OF CANCER, 124, 67-76.
22: Draulans, C., Everaerts, W., Isebaert, S., Van Bruwaene, S., Gevaert, T., Oyen, R., Joniau, S., Lerut, E., De Wever, L., Laenen, A., Weynand, B., Defraene, G., Vanhoutte, E., De Meerleer, G., Haustermans, K. (2019). Development and External Validation of a mpMRI- and ISUP-Based Add-on Prediction Tool to Identity Prostate Cancer Candidates for Pelvic Lymph Node Dissection. JOURNAL OF UROLOGY. [Epub ahead of print].
23: Draulans, C., De Roover, R., van der Heide, U.A., Haustermans, K., Pos, F., Seenk, R.J M., De Boer, H., Depuydt, T., Kunze-Buhsc, M., Isebaert, S., Kerkmeijer, L. (2019). Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus. RADIOTHERAPY AND ONCOLOGY, 140, 131-142.
24: del Campo, E.R., Matzinger, O., Haustermans, K., Peiffert, D., Glynne-Jones, R., Winter, K.A., Konski, A.A., Ajani, J.A., Bosset, J-F., Hannoun-Levi, J-M., Puyraveau, M., Chakravarthy, A.B., Meadows, H., Northover, J., Collette, L., Christiaens, M., Maingon, P. (2019). Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). EUROPEAN JOURNAL OF CANCER, 121, 130-143.
25: Thomas, M., Defraene, G., Lambrecht, M., Deng, W., Moons, J., Nafteux, P., Lin, S.H., Haustermans, K. (2019). NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer. RADIOTHERAPY & ONCOLOGY.
26: van Houdt, P.J., Ghobadi, G., Schoots, I.G., Heijmink, S.W T P J., de Jong, J., van der Poel, H.G., Pos, F.J., Rylander, S., Bentzen, L., Haustermans, K., van der Heide, U.A. (2019). Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions. JOURNAL OF MAGNETIC RESONANCE IMAGING.
27: Fossati, N., Robesti, D., Karnes, R.J., Soligo, M., Boorjian, S.A., Bossi, A., Coraggio, G., Di Muzio, N., Cozzarini, C., Chiorda, B.N., Gandaglia, G., Scarcella, S., Bartkowiak, D., Boehmer, D., Shariat, S., Goldner, G., Battaglia, A., Joniau, S., Hausterrnans, K., De Meerleer, G., Fonteyne, V., Ost, P., Van Poppel, H., Montorsi, F., Wiegel, T., Briganti, A. (2019). Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. EUROPEAN UROLOGY, 76 (4), 443-449.
28: Berghen, C., Joniau, S., Ost, P., Poels, K., Everaerts, W., Decaestecker, K., Haustermans, K., Devos, G., De Meerleer, G. (2019). Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer. European Urology Oncology.
29: Bulens, P., Couwenberg, A., Intven, M., Debucquoy, A., Vandecaveye, V., Van Cutsem, E., D'Hoore, A., Wolthuis, A., Mukherjee, Haustermans, K., P., Gevaert, O. (2019). Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics. RADIOTHERAPY AND ONCOLOGY, AUG 17. [Epub ahead of print].
30: Valentini, V., Marijnen, C., Beets, G., Bujko, K., De Bari, B., Cervantes, A., Chiloiro, G., Coco, C., Gambacorta, M., Haustermans, K., Glynne-Jones, R. The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. RADIOTHERAPY AND ONCOLOGY, AUG 17. [Epub ahead of print].
31: Thomas, M., Borggreve, A., van Rossum, P., Perneel, C., Moons, J., Van Daele, E., van Hillegersberg, R., Deng, W., Pattyn, P., Haustermans, K., Mook, S. (2019). Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis. ACTA ONCOLOGICA. JUL 31. [Epub ahead of print].
32: Draulans, C., De Roover, R., van der Heide, U., Haustermans, K., Pos, F., Smeenk, R., De Boer H, Depuydt T, Kunze-Busch M, Isebaert S. (2019). Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus. RADIOTHERAPY AND ONCOLOGY, 140, 131-142
33: Depypere, L., Thomas, M., Moons, J., Coosemans, W., Lerut, T, Prenen, H., Haustermans, K., Van Veer, H., Nafteux, P. (2019). Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy. World Journal Of Surgical Oncology 17,(89), 1-9.
34: Konings, K., Vandevoorde, C., Belmans, N., Vermeesen, R., Baselet, B., Van Walleghem, M., Janssen, A., Isebaert, S., Baatout, S., Haustermans, K. (2019). The Combination of Particle Irradiation With the Hedgehog Inhibitor GANT61 Differently Modulates the Radiosensitivity and Migration of Cancer Cells Compared to X-Ray Irradiation. FRONTIERS IN ONCOLOGY, 9, 391.
35: Klawer, E., van Houdt, P., Simonis, F., van den Berg, C., Pos, F., Heijmink, S., Isebaert, S., Haustermans, K., van der Heide, U. (2019). Improved repeatability of dynamic contrast‐enhanced MRI using the complex MRI signal to derive arterial input functions: a test‐retest study in prostate cancer patients. MAGNETIC RESONANCE IN MEDICINE, 81(5), 3358-3369.
36: Draulans, C., Everaerts, W., Isebaert, S., Gevaert, T., Oyen, R., Joniau, S., Lerut, E., De Wever, L., Weynand, B., Vanhoutte, E., De Meerleer, G., Haustermans, K. (2019). Impact of MRI on prostate cancer staging and EAU risk classification. UROLOGY, 130, 113-119.
37: Haustermans, K., Thomas, M., & Lambrecht, M. (2019). The potential of proton therapy in oesophageal cancer treatment. BELGIAN JOURNAL OF MEDICAL ONCOLOGY, 13(1), 11-15.
38: Berghen, C., Albersen, M., Blanchard, P., Bossi, A., Briganti, A., Cozzarini, C., Decaestecker, K., Fonteyne V., Haustermans, K., Joniau, S., Lim Joon, D., Khoo, V., Nguyen, P., Ost, P., Villeirs, G., Vulsteke, C., Zietman, A., De Meerleer, G. (2019). Readressing the rationale of irradiation in Stage I seminoma guidelines: A critical essay. BRITISH JOURNAL OF UROLOGY INTERNATIONAL, 124(1), 35-39.
39: De Roover, R., Crijns, W., Poels, K., Michiels, S., Nulens, A., Vanstraelen, B., Petillion, S., Debrandere, M., Haustermans, K., Depuydt, T. (2019). Validation and IMRT/VMAT delivery quality of a preconfigured fast-rotating O-ring linac system. MEDICAL PHYSICS, 46(1), 328-339.
40: Tosco, L., Briganti, A., D'amico, A. V., Eastham, J., Eisenberger, M., Gleave, M., Haustermans, K ., Logothetis, C., Saad, F., Sweeney, C., Taplin, M., Fizazi, K. (2019). Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. EUROPEAN UROLOGY, 75(1), 44-60.

2018

1: Penninckx, S, Heuskin, A-C, Michiels, C & Lucas, S 2018, 'The role of thioredoxin reductase in gold nanoparticle radiosensitization effects' Nanomedicine. https://doi.org/10.2217/nnm-2018-0171
2: Genard, G, Wera, AC, Huart, C, Le Calve, B, Penninckx, S, Fattaccioli, A, Tabarrant, T, Demazy, C, Ninane, N, Heuskin, AC, Lucas, S & Michiels, C 2018, 'Proton irradiation orchestrates macrophage reprogramming through NFκB signaling' Cell Death and Disease, vol. 9, no. 7, 728. https://doi.org/10.1038/s41419-018-0757-9
3: Longton, E, Schmit, K, Fransolet, M, Clement, F & Michiels, C 2018, 'Appropriate sequence for afatinib and cisplatin combination improves anticancer activity in head and neck squamous cell carcinoma' Frontiers in Oncology, vol. 8, no. OCT, 432, pp. 432. https://doi.org/10.3389/fonc.2018.00432
4: Nestle, Ursula ; De Ruysscher, Dirk ; Ricardi, Umberto ; Geets, Xavier ; Belderbos, Jose ; Pöttgen, Christoph ; Dziadiuszko, Rafal ; Peeters, Stephanie ; Lievens, Yolande ; Hurkmans, Coen ; Slotman, Ben ; Ramella, Sara ; Faivre-Finn, Corinne ; McDonald, Fiona ; Manapov, Farkhad ; Putora, Paul Martin ; LePéchoux, Cécile ; Van Houtte, Paul. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.. In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Vol. 127, no. 1, p. 1-5 (2018). doi:10.1016/j.radonc.2018.02.023. http://hdl.handle.net/2078.1/209239
5: Di Perri, Dario ; Colot, Andréa ; Delor, Antoine ; Ghoul, Randa ; Janssens, Guillaume ; Lacroix, Valérie ; Matte, Pascal ; Robert, Annie ; Souris, Kevin ; Geets, Xavier. Effect of continuous positive airway pressure administration during lung stereotactic ablative radiotherapy: a comparative planning study.. In: Strahlentherapie und Onkologie, Vol. 194, no.6, p. 591-599 (2018). doi:10.1007/s00066-018-1278-2. http://hdl.handle.net/2078.1/202793
6: Bernatowicz, Kinga ; Geets, Xavier ; Barragan Montero, Ana Maria ; Janssens, Guillaume ; Souris, Kevin ; Sterpin, Edmond. Feasibility of online IMPT adaptation using fast, automatic and robust dose restoration. In: Physics in Medicine and Biology, Vol. 63, no. 8, p. 085018 [1-13] (2018). doi:10.1088/1361-6560/aaba8c. http://hdl.handle.net/2078.1/207855
7: Langendijk, J., Troost, E., Haustermans, K., Grau, C., Weber, D. (2018). Reply to Laprie A. et al. RADIOTHERAPY AND ONCOLOGY, 130(194).
8: Van den Eynde, M., Mlecnik, B., Bindea, G., Fredriksen, T., Church, S. E., Lafontaine, L., Haicheur, N., Marliot, F., Angelova, M., Vasaturo, A., Bruni, D., Journet-Mourin, A., Baldin, P., Huyghe, N., Haustermans, K., Debucquoy, A., Van Cutsem, E., Gigot, JF., Galon, J. (2018). The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients. CANCER CELL, 34(6), 1012.
9: Bulens, P., Thomas, M., Deroose, C. M., & Haustermans, K. (2018). PET imaging in adaptive radiotherapy of gastrointestinal tumors. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 62(4), 385-403.
10: Draulans, C., Joniau, S., Fonteyne, V., Delrue, L., Decaestecker, K., Everaerts, W., Dirix, P., Van den Bergh, L., Crijns, W., Vandendriessche, H., Van Wynsberge, L, Ost, P., Lumen, N., Buelens, PJ., Haustermans, K., Berghen, C., De Meerleer, G. (2018). Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial. JMIR RESEARCH PROTOCOLS, 7(12), 12 pages.
11: Van Schie, M., Dinh, C., Van Houdt, P., Pos, F., Heijmink, S., Kerkmeijer, L., Kotte, A., Oyen, R., Haustermans, K., Van der Heide, U. (2018). Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trial. RADIOTHERAPY AND ONCOLOGY, 128(2), 321-326.
12: Langendijk, J., Orecchia, R., Haustermans, K., Zips, D., Balosso, J., Lacombe, D., Lievens, Y., Weber, DC., Grau, C., Troost, E. (2018). Prospective data registration and clinical trials for particle therapy in Europe. RADIOTHERAPY AND ONCOLOGY, 128(1), 9-13.
13: Michiels, S., Barragan, AM., Souris, K., Poels, K., Crijns, W., Lee, JA., Sterpin, E., Nuyts, S., Haustermans, K., Depuydt T. (2018). Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization. RADIOTHERAPY AND ONCOLOGY, 128(1), 161-166.
14: Tosco, L., Laenen, A., Gevaert, T., Salmon, I., Decaestecker, C., Davicioni, E., Joniau, S., Haustermans, K. (2018). Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC CANCER, 18(1), 354.
15: Gandaglia, G., Fossati, N., Karnes, R. J., Boorjian, S. A., Colicchia, M., Bossi, A., Briganti, A., Haustermans, K. (2018). Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. EUROPEAN UROLOGY, 73(4), 512-518.
16: De Roover, R., Crijns, W., Poels, K., Peeters, R., Draulans, C., Haustermans, K., Depuydt, T. (2018). Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer. MEDICAL PHYSICS, 45(5), 2205-2217.
17: Gonnissen, A., Isebaert, S., Perneel, C., McKee, C. M., Van Utterbeeck, F., Lerut, E., Haustermans, K. (2018). Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients. AMERICAN JOURNAL OF PATHOLOGY, 188(3), 795-804.
18: Tommelein, J., De Vlieghere, E., Verset, L., Melsens, E., Leenders, J., Descamps, B., De Wever, O., Haustermans, K. (2018). Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation. CANCER RESEARCH, 78(3), 659-670.
19: Allum, W., Lordick, F., Alsina, M., Andritsch, E., Ba-Ssalamah, A., Beishon, M., Naredi, P. Z., Haustermans, K. (2018). ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 122, 179-193.
20: Michiels, S., Poels, K., Crijns, W., Delombaerde, L., De Roover, R., Vanstraelen, B., Depuydt, T., Haustermans, K. (2018). Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linac. RADIOTHERAPY AND ONCOLOGY, 128(3), 479-484.
21: Monninkhof, E. M., van Loon, J. W. L., van Vulpen, M., Kerkmeijer, L. G. W., Pos, F. J., Haustermans, K., van der Heide, U. A. (2018). Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial. RADIOTHERAPY AND ONCOLOGY, 127(1), 74-80.
22: Bulens, P., Couwenberg, A., Haustermans, K., Debucquoy, A., Vandecaveye, V., Philippens, M., Intven, M. (2018). Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer. RADIOTHERAPY AND ONCOLOGY, 126(3), 437-442.

2017

1: Heuskin, A-C, Lucas, S, Michiels, C, Feron, O, MARTINIVE, P & Gallez , B 2017, 'Metallic nanoparticles irradiated by low energy protons for radiation therapy: are there significant physical effects to enhance the dose delivery?' Medical physics, vol. 44, no. 8, pp. 4299-4312.
2: Genard, G, Lucas, S & Michiels, C 2017, 'Reprogramming of tumor-associated macrophages with anticancer therapies: Radiotherapy versus chemo- and immunotherapies' Frontiers in Immunology, vol. 8, no. JUL, 828. https://doi.org/10.3389/fimmu.2017.00828
3: Wanet, Marie ; Delor, Antoine ; Hanin, François-Xavier ; Ghaye, Benoît ; Van Maanen, Aline ; Remouchamps, Vincent ; Clermont, Christian ; Goossens, Samuel ; Lee, John Aldo ; Janssens, Guillaume ; Bol, Anne ; Geets, Xavier. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging. In: Strahlentherapie und Onkologie, Vol. 193, no. 10, p. 812-822 (2017). doi:10.1007/s00066-017-1168-z. http://hdl.handle.net/2078.1/186658
4: Hatt, Mathieu ; Lee, John Aldo ; Schmidtlein, Charles R ; Naqa, Issam El ; Caldwell, Curtis ; De Bernardi, Elisabetta ; Lu, Wei ; Das, Shiva ; Geets, Xavier ; Grégoire, Vincent ; Jeraj, Robert ; MacManus, Michael P ; Mawlawi, Osama R ; Nestle, Ursula ; Pugachev, Andrei B ; Schöder, Heiko ; Shepherd, Tony ; Spezi, Emiliano ; Visvikis, Dimitris ; Zaidi, Habib ; Kirov, Assen S. Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.. In: Medical physics, Vol. 44, no. 6, p. e1-e42 (2017). doi:10.1002/mp.12124. http://hdl.handle.net/2078.1/194729
5: Di Perri, Dario ; Lee, John Aldo ; Bol, Anne ; Hanin, François-Xavier ; Janssens, Guillaume ; Labar, Daniel ; Robert, Annie ; Sterpin, Edmond ; Geets, Xavier. Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy. In: Acta Oncologica, Vol. 56, p. 1181-1188 (2017). doi:10.1080/0284186x.2017.1329594. http://hdl.handle.net/2078.1/194125
6: Di Perri, Dario ; Lee, John Aldo ; Bol, Anne ; Hanin, François-Xavier ; Janssens, Guillaume ; Labar, Daniel ; Robert, Annie ; Sterpin, Edmond ; Geets, Xavier. Evolution of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy.. In: Acta Oncologica, Vol. 56, no. 4, p. 516-524 (2017). doi:10.1080/0284186X.2017.1287943. http://hdl.handle.net/2078.1/194126
7: Habraken, S. J. M., Sharfo, A. W. M., Buijsen, J., Verbakel, W. F. A. R., Haasbeek, C. J. A., Ollers, M. C., Romero, A. M., Haustermans, K. (2017). The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results. RADIOTHERAPY AND ONCOLOGY, 125(3), 507-513.
8: Thomas, M., Haustermans, K. (2017). Radiotherapie bij het maagcarcinoom. ONCO, 11(6), 39-44.
9: Gonnissen, A., Isebaert, S., Perneel, C., McKee, C. M., Verrill, C., Bryant, R. J., Muschel, R. J., Haustermans, K. (2017). Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer. BMC CANCER, 17(1), 634.
10: Stuyck, C., Wegge, M., Bulens, P., Joye, I., Haustermans, K. (2017). Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer. ACTA ONCOLOGICA, 56(11), 1501-1506.
11: Fossati, N., Karnes, R. J., Colicchia, M., Boorjian, S. A., Bossi, A., Seisen, T., Briganti, A., Haustermans, K. (2018). Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. EUROPEAN UROLOGY, 73(3), 436-444.
12: Joye, I., Debucquoy, A., Deroose, C. M., Vandecaveye, V., Van Cutsem, E., Wolthuis, A., Haustermans, K. (2017). Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer. RADIOTHERAPY AND ONCOLOGY, 124(1), 104-109.
13: Veereman, G., Vlayen, J., Robays, J., Fairon, N., Stordeur, S., Rolfo, C., Peeters, M., Haustermans, K. (2017). Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard? CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 114, 43-52.
14: Tosco, L., Laenen, A., Briganti, A., Gontero, P., Karnes, R. J., Albersen, M., Joniau, S., Haustermans, K. (2017). The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer. PROSTATE CANCER AND PROSTATIC DISEASES, 20(4), 407-412.
15: Callens, M. B., Crijns, W., Depuydt, T., Haustermans, K., Maes, F., D'Agostino, E., Van den Abeele, K. (2017). Modeling the dose dependence of the vis-absorption spectrum of EBT3 GafChromic (TM) films. MEDICAL PHYSICS, 44(6), 2532-2543.
16: Leong, T., Smithers, B. M., Haustermans, K., Michael, M., Gebski, V., Miller, D., Wong, R. (2017). TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG. ANNALS OF SURGICAL ONCOLOGY, 24(8), 2252-2258.
17: Cuong, V. D., Steenbergen, P., Ghobadi, G., van der Poel, H., Heijmink, S. W. T. P. J., de Jong, J., van der Heide, U. A., Haustermans, K. (2017). Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledge. MEDICAL PHYSICS, 44(3), 949-961.
18: Gonnissen, A., Isebaert, S., McKee, C. M., Muschel, R. J., Haustermans, K. (2017). The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18(2).
19: Tosco, L., Laenen, A., Briganti, A., Gontero, P., Karnes, R. J., Bastian, P. J., Haustermans, K., European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT). (2017). The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. EUROPEAN UROLOGY FOCUS.
20: Gonnissen, A., Isebaert, S., McKee, C. M., Dok, R., Haustermans, K., Muschel, R. J. (2016). The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo. ONCOTARGET, 7(51), 84286-84298.
21: Van Laethem, J. L., Carneiro, F., Ducreux, M., Messman, H., Lordick, F., Ilson, D. H., Seufferlein, T., Haustermans, K. (2016). The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona. DIGESTIVE AND LIVER DISEASE, 48(11), 1283-1289.
22: Lutz, M. P., Zalcberg, J. R., Glynne-Jones, R., Ruers, T., Ducreux, M., Arnold, D., Otto, F., Haustermans, K. (2016). 2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer (vol 63, pg 11, 2016). EUROPEAN JOURNAL OF CANCER, 68, 208-209.
23: Demey, K., Van Veer, H., Nafteux, P., Deroose, C. M., Haustermans, K., Coolen, J., Van Cutsem, E. (2017). Hepatic radiation injury mimicking metastasis in distal esophageal cancer. ACTA CHIRURGICA BELGICA, 117(4), 250-255.

2016

1: Li, S, Penninckx, S, Karmani, L, Heuskin, AC, Watillon, K, Marega, R, Zola, J, Corvaglia, V, Genard, G, Gallez, B, Feron, O, Martinive, P, Bonifazi, D, Michiels, C & Lucas, S 2016, 'LET-dependent radiosensitization effects of gold nanoparticles for proton irradiation' Nanotechnology, vol. 27, no. 45, 455101. https://doi.org/10.1088/0957-4484/27/45/455101
2: Suetens, A., Konings, K., Moreels, M., Quintens, R., Verslegers, M., Soors, E., ... Baatout, S. (2016). Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells. Frontiers in Oncology, 6, [87]. https://doi.org/10.3389/fonc.2016.00087
3: Scrivener, Madeleine ; de Jong, Evelyn E. C. ; van Timmeren, Janna E. ; Pieters, Thierry ; Ghaye, Benoît ; Geets, Xavier. Radiomics applied to lung cancer: a review. In: Translational Cancer Research, Vol. 5, no.4, p. 398-409 (2016). doi:10.21037/tcr.2016.06.18. http://hdl.handle.net/2078.1/184762
4: Dirix, P., Vingerhoedt, S., Joniau, S., Van Cleynenbreugel, B., Haustermans, K. (2016). Hypofractionated palliative radiotherapy for bladder cancer. SUPPORTIVE CARE IN CANCER, 24(1), 181-186 DOI: 10.1007/s00520-015-2765-y
5: Moris, L., Van den Broeck, T., Tosco, L., Van Baelen, A., Gontero, P., Karnes, R. J., Joniau, S., Haustermans, K. (2016). Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection. FRONTIERS IN SURGERY, 3.
6: Joye, I., Silversmit, G., Van Eycken, E., Debucquoy, A., Vandendael, T., Penninckx, F., Haustermans, K. (2016). Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison. CANCER EPIDEMIOLOGY, 43, 35-41.
7: Maleux, G., Deroose, C., Laenen, A., Verslype, C., Heye, S., Haustermans, K., Van Cutsem, E. (2016). Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. ACTA ONCOLOGICA, 55(4), 486-495
8: Callens, M., Crijns, W., Simons, V., De Wolf, I., Depuydt, T., Maes, F., Van den Abeele, K., Haustermans, K. (2016). A spectroscopic study of the chromatic properties of GafChromic (TM) EBT3 films. MEDICAL PHYSICS, 43(3), 1156-1166
9: Van Binnebeek, S., Vanbilloen, B., Baete, K., Terwinghe, C., Koole, M., Mottaghy, F. M., Deroose, C. M., Haustermans, K. (2016). Comparison of diagnostic accuracy of In-111-pentetreotide SPECT and Ga-68-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. EUROPEAN RADIOLOGY, 26(3), 900-909
10: Spans, L., Van den Broeck, T., Smeets, E., Prekovic, S., Thienpont, B., Lambrechts, D., Claessens, F., Haustermans, K. (2016). Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. ONCOTARGET, 7(7), 24326-24338
11: Dinh, C. V., Steenbergen, P., Ghobadi, G., Heijmink, S. W. T. J. P., Pos, F. J., Haustermans, K., van der Heide, U. A. (2016). Magnetic resonance imaging for prostate cancer radiotherapy. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(3), 446-451.
12: Fossati, N., Karnes, R. J., Cozzarini, C., Fiorino, C., Gandaglia, G., Joniau, S., Briganti, A., Haustermans, K. (2016). Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. EUROPEAN UROLOGY, 69(4), 728-733.
13: Spans, L., Van den Broeck, T., Smeets, E., Prekovic, S., Thienpont, B., Lambrechts, D., Claessens, F., Haustermans, K. (2016). Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. ONCOTARGET, 7(17), 24326-24338.
14: Crijns, W., Defraene, G., Van Herck, H., Depuydt, T., Haustermans, K., Maes, F., Van den Heuvel, F. (2016). Potential benefits of dosimetric VMAT tracking verified with 3D film measurements. MEDICAL PHYSICS, 43(5).
15: Van Binnebeek, S., Koole, M., Terwinghe, C., Baete, K., Vanbilloen, B., Haustermans, K., Deroose, C. M. (2016). Dynamic Ga-68-DOTATOC PET/CT and static image in NET patients Correlation of parameters during PRRT. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 55(3), 104-114.
16: Joye, I., Haustermans, K. (2016). Which Patients With Rectal Cancer Do Not Need Radiotherapy? SEMINARS IN RADIATION ONCOLOGY, 26(3), 199-204.
17: Joye, I., Debucquoy, A., Fieuws, S., Wolthuis, A., Sagaert, X., D'Hoore, A., Haustermans, K. (2016). Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer? ACTA ONCOLOGICA, 55(8), 1047-1052.
18: Joye, I., Macq, G., Vaes, E., Roels, S., Lambrecht, M., Pelgrims, A., Haustermans, K. (2016). Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project. RADIOTHERAPY AND ONCOLOGY, 120(2), 202-206.
19: Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Arnold, D., Haustermans, K. (2016). ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. ANNALS OF ONCOLOGY, 27(8), 1386-1422.
20: Valentini, V., Gambacorta, M. A., Barbaro, B., Chiloiro, G., Coco, C., Das, P., Haustermans, K. (2016). International consensus guidelines on Clinical Target Volume delineation in rectal cancer. RADIOTHERAPY AND ONCOLOGY, 120(2), 195-201.
21: Lutz, M. P., Zalcberg, J. R., Glynne-Jones, R., Ruers, T., Ducreux, M., Arnold, D., Otto, F., Haustermans, K. (2016). Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. EUROPEAN JOURNAL OF CANCER, 63, 11-24.
22: Lordick, F., Mariette, C., Haustermans, K., Obermannova, R., Arnold, D. (2016). Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 27, v50-v57.
23: Demetter, P., Jouret-Mourin, A., Silversmit, G., Vandendael, T., Sempoux, C., Hoorens, A., Penninckx, F., Haustermans, K. (2016). Review of the quality of total mesorectal excision does not improve the prediction of outcome. COLORECTAL DISEASE, 18(9), 883-888.
24: Fiorino, C., Broggi, S., Fossati, N., Cozzarini, C., Goldner, G., Wiegel, T., Briganti, A., Haustermans, K. (2016). Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in >= PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), 333-340.
25: Michiels, S., D'Hollander, A., Lammens, N., Kersemans, M., Zhang, G., Denis, J. M., Depuydt, T., Haustermans, K. (2016). Towards 3D printed multifunctional immobilization for proton therapy: Initial materials characterization. MEDICAL PHYSICS, 43(10), 5392-5402.
26: Michiels, S., D'Hollander, A., Lammens, N., Kersemans, M., Zhang, G., Denis, J. M., Depuydt, T., Haustermans, K. (2016). Towards 3D printed multifunctional immobilization for proton therapy: Initial materials characterization. MEDICAL PHYSICS, 43(10), 5392-5402.
27: Fiorino, C., Broggi, S., Fossati, N., Cozzarini, C., Goldner, G., Wiegel, T., Briganti, A., Haustermans, K. (2016). Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in >= PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), 333-340.
28: Demetter, P., Jouret-Mourin, A., Silversmit, G., Vandendael, T., Sempoux, C., Hoorens, A., Penninckx, F., Haustermans, K. (2016). Review of the quality of total mesorectal excision does not improve the prediction of outcome. COLORECTAL DISEASE, 18(9), 883-888.
29: Lordick, F., Mariette, C., Haustermans, K., Obermannova, R., Arnold, D. (2016). Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 27, v50-v57.
30: Lutz, M. P., Zalcberg, J. R., Glynne-Jones, R., Ruers, T., Ducreux, M., Arnold, D., Otto, F., Haustermans, K. (2016). Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. EUROPEAN JOURNAL OF CANCER, 63, 11-24.
31: Valentini, V., Gambacorta, M. A., Barbaro, B., Chiloiro, G., Coco, C., Das, P., Haustermans, K. (2016). International consensus guidelines on Clinical Target Volume delineation in rectal cancer. RADIOTHERAPY AND ONCOLOGY, 120(2), 195-201.
32: Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Arnold, D., Haustermans, K. (2016). ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. ANNALS OF ONCOLOGY, 27(8), 1386-1422.
33: Joye, I., Macq, G., Vaes, E., Roels, S., Lambrecht, M., Pelgrims, A., Haustermans, K. (2016). Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project. RADIOTHERAPY AND ONCOLOGY, 120(2), 202-206.
34: Joye, I., Debucquoy, A., Fieuws, S., Wolthuis, A., Sagaert, X., D'Hoore, A., Haustermans, K. (2016). Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer? ACTA ONCOLOGICA, 55(8), 1047-1052.
35: Joye, I., Haustermans, K. (2016). Which Patients With Rectal Cancer Do Not Need Radiotherapy? SEMINARS IN RADIATION ONCOLOGY, 26(3), 199-204.
36: Van Binnebeek, S., Koole, M., Terwinghe, C., Baete, K., Vanbilloen, B., Haustermans, K., Deroose, C. M. (2016). Dynamic Ga-68-DOTATOC PET/CT and static image in NET patients Correlation of parameters during PRRT. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 55(3), 104-114.
37: Crijns, W., Defraene, G., Van Herck, H., Depuydt, T., Haustermans, K., Maes, F., Van den Heuvel, F. (2016). Potential benefits of dosimetric VMAT tracking verified with 3D film measurements. MEDICAL PHYSICS, 43(5).
38: Spans, L., Van den Broeck, T., Smeets, E., Prekovic, S., Thienpont, B., Lambrechts, D., Claessens, F., Haustermans, K. (2016). Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. ONCOTARGET, 7(17), 24326-24338.
39: Fossati, N., Karnes, R. J., Cozzarini, C., Fiorino, C., Gandaglia, G., Joniau, S., Briganti, A., Haustermans, K. (2016). Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. EUROPEAN UROLOGY, 69(4), 728-733.
40: Dinh, C. V., Steenbergen, P., Ghobadi, G., Heijmink, S. W. T. J. P., Pos, F. J., Haustermans, K., van der Heide, U. A. (2016). Magnetic resonance imaging for prostate cancer radiotherapy. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(3), 446-451.
41: Spans, L., Van den Broeck, T., Smeets, E., Prekovic, S., Thienpont, B., Lambrechts, D., Claessens, F., Haustermans, K. (2016). Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. ONCOTARGET, 7(7), 24326-24338.
42: Van Binnebeek, S., Vanbilloen, B., Baete, K., Terwinghe, C., Koole, M., Mottaghy, F. M., Deroose, C. M., Haustermans, K. (2016). Comparison of diagnostic accuracy of In-111-pentetreotide SPECT and Ga-68-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. EUROPEAN RADIOLOGY, 26(3), 900-909.
43: Callens, M., Crijns, W., Simons, V., De Wolf, I., Depuydt, T., Maes, F., Van den Abeele, K., Haustermans, K. (2016). A spectroscopic study of the chromatic properties of GafChromic (TM) EBT3 films. MEDICAL PHYSICS, 43(3), 1156-1166.
44: Maleux, G., Deroose, C., Laenen, A., Verslype, C., Heye, S., Haustermans, K., Van Cutsem, E. (2016). Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. ACTA ONCOLOGICA, 55(4), 486-495.
45: Joye, I., Silversmit, G., Van Eycken, E., Debucquoy, A., Vandendael, T., Penninckx, F., Haustermans, K. (2016). Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison. CANCER EPIDEMIOLOGY, 43, 35-41.
46: Moris, L., Van den Broeck, T., Tosco, L., Van Baelen, A., Gontero, P., Karnes, R. J., Joniau, S., Haustermans, K. (2016). Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection. FRONTIERS IN SURGERY, 3.
47: Dirix, P., Vingerhoedt, S., Joniau, S., Van Cleynenbreugel, B., Haustermans, K. (2016). Hypofractionated palliative radiotherapy for bladder cancer. SUPPORTIVE CARE IN CANCER, 24(1), 181-186.

Publications

2021

2020

2019

2018

2017

2016

Share this page